Cargando…

Hsa-miR-149-5p Suppresses Prostate Carcinoma Malignancy by Suppressing RGS17

BACKGROUND: MicroRNAs (miRNAs) are key players in the progression of human cancers. While several miRNAs have been reported to regulate the development of tumors, the molecular mechanisms and roles of miR-149-5p in prostate carcinoma (PCa) remain unclear. Our aim was to investigate the interaction a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Jinhua, Wei, Hongbing, Li, Xianlin, Qu, Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007479/ https://www.ncbi.nlm.nih.gov/pubmed/33790651 http://dx.doi.org/10.2147/CMAR.S281968

Ejemplares similares

Upregulation Of miR-149-3p Suppresses Spinal Chordoma Malignancy By Targeting Smad3
por: Yao, Jie, et al.
Publicado: (2019)

Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2016)

Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2017)

miR-149 Suppresses the Proliferation and Metastasis of Human Gastric Cancer Cells by Targeting FOXC1
por: Li, Dan, et al.
Publicado: (2021)

Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2018)

Comprehensive Analysis of hsa-miR-654-5p’s Tumor-Suppressing Functions
por: Liu, Chuanyang, et al.
Publicado: (2022)

miR-17* Suppresses Tumorigenicity of Prostate Cancer by Inhibiting Mitochondrial Antioxidant Enzymes
por: Xu, Yong, et al.
Publicado: (2010)

Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
por: Lopes, Camile B., et al.
Publicado: (2018)

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies
por: Chim, Chor Sang, et al.
Publicado: (2011)

CeRNA network identified hsa-miR-17-5p, hsa-miR-106a-5p and hsa-miR-2355-5p as potential diagnostic biomarkers for tuberculosis
por: Song, Jie, et al.
Publicado: (2023)

Sevoflurane suppresses the malignant progression of breast cancer via the hsa_circ_0000129/miR‐578/EPSTI1 axis
por: Zeng, Xuehui, et al.
Publicado: (2023)

Hsa_circ_0017728 as an oncogene in gastric cancer by sponging miR-149 and modulating the IL-6/STAT3 pathway
por: Yang, Chun, et al.
Publicado: (2019)

Hsa_circ_0046264 up-regulated BRCA2 to suppress lung cancer through targeting hsa-miR-1245
por: Yang, Liu, et al.
Publicado: (2018)

Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer
por: Wilting, Saskia M, et al.
Publicado: (2010)

Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2019)

Hsa-miR-599 suppresses the migration and invasion by targeting BRD4 in breast cancer
por: Wang, Yonghui, et al.
Publicado: (2017)

hsa_circ_0003738 Inhibits the Suppressive Function of Tregs by Targeting miR-562/IL-17A and miR-490-5p/IFN-γ Signaling Pathway
por: Yang, Luting, et al.
Publicado: (2020)

Hsa_circ_0110757 upregulates ITGA1 to facilitate temozolomide resistance in glioma by suppressing hsa-miR-1298-5p
por: Li, Haoyu, et al.
Publicado: (2021)

Lack of Association between Hsa-miR-149 rs2292832 Polymorphism and Cancer Risk: A Meta-Analysis of 12 Studies
por: Xu, Lei, et al.
Publicado: (2013)

The circular RNA hsa_circ_0003091 regulates sepsis-induced lung injury by sponging the miR-149/Smad2 axis
por: Shen, Mei-Jia, et al.
Publicado: (2022)

Targeting of GIT1 by miR-149* in breast cancer suppresses cell proliferation and metastasis in vitro and tumor growth in vivo
por: Dong, Yan, et al.
Publicado: (2017)

18β-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling
por: Cao, Donghui, et al.
Publicado: (2016)

miR-149 in Human Cancer: A Systemic Review
por: He, Yunjie, et al.
Publicado: (2018)

hsa_circ_0004018 suppresses the progression of liver fibrosis through regulating the hsa-miR-660-3p/TEP1 axis
por: Li, Shan, et al.
Publicado: (2020)

Hsa_circ_0003602 Contributes to the Progression of Colorectal Cancer by Mediating the miR-149-5p/SLC38A1 Axis
por: Wu, Rong, et al.
Publicado: (2023)

Macrophage miR-149-5p induction is a key driver and therapeutic target for BRONJ
por: Shen, Xin, et al.
Publicado: (2022)

By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer
por: Zhang, Zun-yi, et al.
Publicado: (2014)

Nerve growth factor promotes lysyl oxidase-dependent chondrosarcoma cell metastasis by suppressing miR-149-5p synthesis
por: Tzeng, Huey-En, et al.
Publicado: (2021)

Targeting of GIT1 by miR-149* in Breast Cancer Suppresses Cell Proliferation and Metastasis in vitro and Tumor Growth in vivo [Retraction]
Publicado: (2022)

miR‑149‑3p suppresses the proliferation and metastasis of glioma cells by targeting the CBX2/Wnt/β‑catenin pathway
por: Wang, Yanjun, et al.
Publicado: (2023)

“Seed-Milarity” Confers to hsa-miR-210 and hsa-miR-147b Similar Functional Activity
por: Bertero, Thomas, et al.
Publicado: (2012)

Correction for: hsa_circ_0004018 suppresses the progression of liver fibrosis through regulating the hsa-miR-660-3p/TEP1 axis
por: Li, Shan, et al.
Publicado: (2021)

Hsa_circ_0000479/Hsa-miR-149-5p/RIG-I, IL-6 Axis: A Potential Novel Pathway to Regulate Immune Response against COVID-19
por: Firoozi, Zahra, et al.
Publicado: (2022)

Fhit induces the reciprocal suppressions between Lin28/Let-7 and miR-17/92miR
por: Chae, Hae-Jung, et al.
Publicado: (2021)

MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)
por: Petty, Robert D., et al.
Publicado: (2016)

Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the Body Mass Index
por: Tesolato, Sofía Elena, et al.
Publicado: (2023)

A Review on the Role of miR-149-5p in the Carcinogenesis
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

miR-505 suppresses prostate cancer progression by targeting NRCAM
por: Ling, Xiao-Hui, et al.
Publicado: (2019)

miR-505 suppresses prostate cancer progression by targeting NRCAM
por: Ling, Xiao-Hui, et al.
Publicado: (2020)

Suppression of ANT2 by miR-137 Inhibits Prostate Tumorigenesis
por: Zhang, Heyuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c9ep9vsv332t9dfaldok9nsieu